Lonza
Lonza is one of the world’s leading and most-trusted suppliers to the pharmaceutical, biotech and specialty ingredients markets. As an integrated solutions provider, Lonza is boosting its value creation along and beyond the healthcare continuum with a strong focus on patient healthcare, consumer preventive healthcare and consumer’s healthy environment.
Lonza harnesses science and technology to create products that support safer and healthier living and that enhance the overall quality of life. With the recent Capsugel acquisition, Lonza now offers products and services from the custom development and manufacturing of active pharmaceutical ingredients to innovative dosage forms for the pharma and consumer health and nutrition industries.
Benefiting from its regulatory expertise, Lonza is able to transfer its know-how from pharma to hygiene and fast-moving consumer goods all the way to coatings and composites and the preservation and protection of agricultural goods and other natural resources.
Associated Experts
Job Title: Head of Expression Systems, Licensing
Job Title: Director Marketing Channels and Communications
Job Title: Business Development Manager for Cell and Viral Therapy Services
Job Title: Head of Innovation
Job Title: Senior Product Manager, Clonetics™ Primary Cells and RAFT™ 3D Cell Culture System
Job Title: Product Manager
Associated Content
Increasing speed and efficiency of biotherapeutic drug development with stable pools
In this podcast, we talked with Dr. Alison Porter, Head of Expression System Sciences, Lonza, about the use of stable pool expression to reduce drug development timelines. Highlights included the implementation of stable pools in current workflows, expected titers, and cutting-edge applications of the technology....Continued
Successful Techniques for Progressing Biotherapeutic Candidates from Discovery to the Clinic
In a recent virtual symposium, Lonza gathered industry experts to provide insight on the resources available for successfully progressing biotherapeutic candidates from discovery to the clinic. Presenters from academia, local biotech companies, and Lonza shared information on new and established technologies enabling translational research....Continued
3D Cell Culture with RAFT™ System – An Introduction
The key differentiation of the RAFT™ System from other platforms is its robustness and versatility. This system can be utilized with one cell type, or multiple cell types in parallel. Cells can be cultured within the collagen scaffold, or on top, or both. The addition of permeable membrane cell culture inserts provides other extensions to the system, allowing the generation of barrier models including air-lift models....Continued
Cord Blood-derived HSCs – The Quest to Overcome Limited Cell Numbers
Despite their potential in combating GVHD, cord blood-derived HSCs also pose a major challenge due to the limited number of cells available from any particular donor. Thus, many research labs and clinical trials are currently focused on developing methods for ex-vivo expansion of cord blood-derived HSCs....Continued